In Vitro and In Vivo Models of Cerebral Ischemia Show Discrepancy in Therapeutic Effects of M2 Macrophages

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Desestret, Virginie ^a,b,c,d   Riou, Adrien ^a   Chauveau, Fabien ^a   Cho, Tae Hee ^a,b,c   Devillard, Emilie ^d   Marinescu, Marilena ^a   Ferrera, René ^c,e   Rey, Catherine ^f   Chanal, Marie ^d   Angoulvant, Denis ^b,c,e   Honnorat, Jérôme ^b,c,d   Nighoghossian, Norbert ^a,b,c   Berthezène, Yves ^a,b,c   Nataf, Serge ^b,c,d   Wiart, Marlène ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d LYON NEUROSCIENCE RESEARCH CENTER   (France)

^e INSERM   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IRON OXIDE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BONE MARROW CELL; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL LOSS; CELL TYPE; CELLULAR IMMUNITY; CLINICAL EFFECTIVENESS; COCULTURE; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE ACTIVATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PHAGOCYTE; POLARIZATION; RAT;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CELL HYPOXIA; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MALE; MICE; NEURONS; RATS; STROKE; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84879373117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067063     Document Type: Article

References (29)

1. Iadecola C, Anrather J, (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808.
2. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, et al. (2009) Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15: 946-950.
3. Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, et al. (2012) Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol 71: 743-752.
4. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M, (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229: 176-185.
5. Schwartz M, (2010) "Tissue-repairing" blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Brain Behav Immun 24: 1054-1057.
6. Shechter R, London A, Varol C, Raposo C, Cusimano M, et al. (2009) Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6: e1000113.
7. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H, (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4: e124.
8. Perego C, Fumagalli S, De Simoni MG, (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation 8: 174-193.
9. Hu X, Li P, Guo Y, Wang H, Leak RK, et al. (2012) Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43: 3063-3070.
10. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, et al. (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40: 2244-2250.
11. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 40: 510-515.
12. Neumann J, Sauerzweig S, Ronicke R, Gunzer F, Dinkel K, et al. (2008) Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci 28: 5965-5975.
13. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
14. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
15. Longa EZ, Weinstein PR, Carlson S, Cummins R, (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
16. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, et al. (2007) Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 27: 6-13.
17. Beaumont M, Lemasson B, Farion R, Segebarth C, Remy C, et al. (2009) Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J Cereb Blood Flow Metab 8: 8-21.
18. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, et al. (2007) Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 27: 1941-1953.
19. Wagner DC, Deten A, Hartig W, Boltze J, Kranz A, (2012) Changes in T2 relaxation time after stroke reflect clearing processes. Neuroimage 61: 780-785.
20. Mantovani A, Sica A, Locati M, (2005) Macrophage polarization comes of age. Immunity 23: 344-346.
21. Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, et al. (2005) A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. Faseb J 19: 1896-1898.
22. Rizk NN, Myatt-Jones J, Rafols J, Dunbar JC, (2007) Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats. Endocrine 31: 66-71.
23. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, et al. (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult Scler 17: 2-15.
24. Sarnowska A, Braun H, Sauerzweig S, Reymann KG, (2009) The neuroprotective effect of bone marrow stem cells is not dependent on direct cell contact with hypoxic injured tissue. Exp Neurol 215: 317-327.
25. Hicks A, Schallert T, Jolkkonen J, (2009) Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 5: 139-140.
26. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, et al. (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40: 1849-1857.
27. Tei N, Tanaka J, Sugimoto K, Nishihara T, Nishioka R, et al. (2013) Expression of MCP-1 and fractalkine on endothelial cells and astrocytes may contribute to the invasion and migration of brain macrophages in ischemic rat brain lesions. J Neurosci Res 91: 681-693.
28. Bliss T, Guzman R, Daadi M, Steinberg GK, (2007) Cell transplantation therapy for stroke. Stroke 38: 817-826.
29. Riou A, Chauveau F, Cho TH, Marinescu M, Nataf S, et al. (2013) MRI assessment of the intra-carotid route for macrophage delivery after transient cerebral ischemia. NMR Biomed 26: 115-123.